BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9430869)

  • 1. Assessment of renal dopaminergic system activity during the recovery of renal function in human kidney transplant recipients.
    Pestana M; Faria MS; Oliveira JG; Baldaia J; Santos A; Guerra LE; Soares-da-Silva P
    Nephrol Dial Transplant; 1997 Dec; 12(12):2667-72. PubMed ID: 9430869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced urinary excretion of dopamine and metabolites in chronic renal parenchymal disease.
    Pestana M; Jardim H; Serrão P; Soares-da-Silva P; Guerra L
    Kidney Blood Press Res; 1998; 21(1):59-65. PubMed ID: 9661138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal dopaminergic mechanisms in renal parenchymal diseases and hypertension.
    Pestana M; Jardim H; Correia F; Vieira-Coelho MA; Soares-da-Silva P
    Nephrol Dial Transplant; 2001; 16 Suppl 1():53-9. PubMed ID: 11369822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of renal dopaminergic system activity during cyclosporine A administration in the rat.
    Pestana M; Vieira-Coelho MA; Pinto-do-O PC; Fernandes MH; Soares-da-Silva P
    Br J Pharmacol; 1995 Aug; 115(8):1349-58. PubMed ID: 8564191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of renal dopaminergic system activity in the nitric oxide-deprived hypertensive rat model.
    Soares-da-Silva P; Pestana M; Vieira-Coelho MA; Fernandes MH; Albino-Teixeira A
    Br J Pharmacol; 1995 Apr; 114(7):1403-13. PubMed ID: 7541690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High sodium intake increases the urinary excretion of L-3,4-dihydroxyphenylalanine but fails to alter the urinary excretion of dopamine and amine metabolites in Wistar rats.
    Vieira-Coelho MA; Pestana M; Soares-da-Silva P
    Gen Pharmacol; 1996 Dec; 27(8):1421-7. PubMed ID: 9304419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal dopaminergic system in nephrotic syndrome and after remission.
    Pestana M; Jardim H; Afonso C; Serrão P; Santos N; Guerra L; Soares-da-Silva P
    Nephrol Dial Transplant; 1998 Oct; 13(10):2559-62. PubMed ID: 9794559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concerted action of dopamine on renal and intestinal Na(+)-K(+)-ATPase in the rat remnant kidney.
    Vieira-Coelho MA; Serrão P; Guimarães JT; Pestana M; Soares-da-Silva P
    Am J Physiol Renal Physiol; 2000 Dec; 279(6):F1033-44. PubMed ID: 11097621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aging, high salt intake, and renal dopaminergic activity in Fischer 344 rats.
    Vieira-Coelho MA; Hussain T; Kansra V; Serrao MP; Guimaraes JT; Pestana M; Soares-Da-Silva P; Lokhandwala MF
    Hypertension; 1999 Oct; 34(4 Pt 1):666-72. PubMed ID: 10523344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure, aging, and renal synthesis of dopamine.
    Ferreira A; Bettencourt P; Pestana M; Correia F; Serrão P; Martins L; Cerqueira-Gomes M; Soares-Da-Silva P
    Am J Kidney Dis; 2001 Sep; 38(3):502-9. PubMed ID: 11532681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deamination of newly-formed dopamine in rat renal tissues.
    Fernandes MH; Pestana M; Soares-da-Silva P
    Br J Pharmacol; 1991 Mar; 102(3):778-82. PubMed ID: 1364853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal dopaminergic mechanisms in renal parenchymal diseases, hypertension, and heart failure.
    Soares-da-Silva P; Pestana M; Ferreira A; Damasceno A; Polónia J; Cerqueira-Gomes M
    Clin Exp Hypertens; 2000 Apr; 22(3):251-68. PubMed ID: 10803731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle.
    Commissiong JW; Slimovitch C; Toffano G
    Br J Pharmacol; 1990 Apr; 99(4):741-9. PubMed ID: 2361171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion of monoamines and their metabolites in patients with Parkinson's disease. Response to long-term treatment with levodopa alone or in combination with a dopa decarboxylase inhibitor and clinical correlations.
    Siirtola T; Sonninen V; Rinne UK
    Clin Neurol Neurosurg; 1975; 78(2):77-88. PubMed ID: 1222507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of plasma 3,4-dihydroxyphenylacetic acid (DOPAC) and plasma 3,4-dihydroxyphenylalanine (DOPA) as tumor markers in children with neuroblastoma.
    Eldrup E; Clausen N; Scherling B; Schmiegelow K
    Scand J Clin Lab Invest; 2001; 61(6):479-90. PubMed ID: 11681538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium-dependence and ouabain-sensitivity of the synthesis of dopamine in renal tissues of the rat.
    Soares-da-Silva P; Fernandes MH
    Br J Pharmacol; 1992 Apr; 105(4):811-6. PubMed ID: 1504714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The renal handling of dopamine originating from L-dopa and gamma-glutamyl-L-dopa.
    Pestana M; Soares-da-Silva P
    Br J Pharmacol; 1994 Jun; 112(2):417-22. PubMed ID: 8075859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal metabolism and effects of the glutamyl derivatives of L-dopa and 5-hydroxytryptophan in man.
    Li Kam Wa TC; Freestone S; Samson RR; Johnston NR; Lee MR
    Clin Sci (Lond); 1996 Aug; 91(2):177-85. PubMed ID: 8795441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A decreased tubular uptake of dopa results in defective renal dopamine production in aged rats.
    Armando I; Nowicki S; Aguirre J; Barontini M
    Am J Physiol; 1995 Jun; 268(6 Pt 2):F1087-92. PubMed ID: 7611449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of type A and B monoamine oxidase selective inhibition by Ro 41-1049 and Ro 19-6327 on dopamine outflow in rat kidney slices.
    Pestana M; Soares-da-Silva P
    Br J Pharmacol; 1994 Dec; 113(4):1269-74. PubMed ID: 7889283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.